President and Chief Executive Officer

Senior Vice President, Franchise Head Epilepsy and Movement Disorders

Jazz Pharmaceuticals Director Sells 5,500 Shares

FDA Approves Jazz Pharmaceuticals plc's Zepzelca (lurbinectedin) and Atezolizumab Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

FDA Approves Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Associate Director, Corporate Counsel, Commercialization and Market Access

Jazz Pharmaceuticals is a global biopharma company dedicated to developing life-changing medicines. The Associate Director, Corporate Counsel, Commercialization and Market Access will provide legal support for brands and business functions, addressing a broad range of legal issues related to FDA regulations and marketing strategies.

Associate Director, Corporate Counsel, Commercialization and Market Access (Remote)

Associate Director, Commercial Strategic Planning and Transformation

Director, Corporate Counsel - Commercialization and Market Access

Director, Corporate Counsel, Commercialization and Market Access

Senior Director, Regulatory Law & Strategy, Legal

Sign up with Google

Sign in with Google